Novartis terminates knee pain study; Telix reports brain tumor data

Plus, news about Tiger Gene and Theratechnologies: Novartis scraps knee pain drug: The Swiss drugmaker discontinued a Phase 2 test of an under-the-skin treatment for knee osteoarthritis ...